Patient organization perspective: a research roadmap for Okur-Chung Neurodevelopmental Syndrome

Area of Science:

• Genetics and Molecular Biology
• Neuroscience
• Rare Diseases

Background:

• Okur-Chung neurodevelopmental syndrome (OCNDS) is an ultra-rare disorder linked to variants in the CSNK2A1 gene.
• CSNK2A1 encodes casein kinase 2 (CK2), a crucial enzyme in neural development, also implicated in various other pathologies.
• Current treatments for OCNDS focus on symptom management due to a lack of approved therapies.

Purpose of the Study:

• To describe OCNDS and the CSNK2A1 gene.
• To highlight existing research gaps and outline a strategic research roadmap.
• To provide a founder's perspective on research progress and future opportunities.

Main Methods:

• Review of existing literature on OCNDS and CSNK2A1.
• Description of the CSNK2A1 Foundation's research initiatives and funding.
• Presentation of a non-linear research roadmap focusing on landscape analysis, biomarker development, and therapeutic testing.

Main Results:

• The CSNK2A1 Foundation has funded research, providing insights into CK2 biology and OCNDS natural history.
• Valuable research tools have been developed and made available to the global scientific community.
• A research roadmap has been established to guide future therapeutic exploration.

Conclusions:

• Further research is essential to fully elucidate OCNDS mechanisms and identify effective treatments.
• Continued investigation of CK2's role in neural development is key to understanding OCNDS and related disorders.
• The developed research roadmap offers a strategic approach to accelerate therapeutic interventions for OCNDS.